These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36544793)

  • 1. A statistical look at the COVID-19 vaccine development and vaccine policies.
    Apio C; Han K; Heo G; Park T
    Front Public Health; 2022; 10():1048062. PubMed ID: 36544793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of geo-political socio-economic factors on vaccine dissemination trends: a case-study on COVID-19 vaccination strategies.
    Chauhan R; Varma G; Yafi E; Zuhairi MF
    BMC Public Health; 2023 Nov; 23(1):2142. PubMed ID: 37919737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world.
    Chavda VP; Yao Q; Vora LK; Apostolopoulos V; Patel CA; Bezbaruah R; Patel AB; Chen ZS
    Front Immunol; 2022; 13():961198. PubMed ID: 36263030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the India COVID-19 vaccine tracker.
    Singh H; Lohia R; George LS; Gupta N; Thangaraj JW; Rana S; Rana S; Kaur J; Shivam S; Arora NK; Muliyil JP; Murhekar MV; Lodha R; Pandey RM; Rao VV; Dhandore S; Malik A; Kumar V; Tripathi A; Panda S; Bhargava B
    Indian J Med Res; 2022; 155(5&6):513-517. PubMed ID: 35859397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
    Forman R; Shah S; Jeurissen P; Jit M; Mossialos E
    Health Policy; 2021 May; 125(5):553-567. PubMed ID: 33820678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations for fair prioritization of COVID-19 vaccine and its mandate among healthcare personnel.
    Hughes K; Gogineni V; Lewis C; Deshpande A
    Curr Med Res Opin; 2021 Jun; 37(6):907-909. PubMed ID: 33760673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the vaccine development for the prophylaxis of SARS Covid-19.
    Kumar V; Kumar S; Sharma PC
    Int Immunopharmacol; 2022 Oct; 111():109175. PubMed ID: 35994853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future.
    Pilkington V; Keestra SM; Hill A
    Front Public Health; 2022; 10():821117. PubMed ID: 35321196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of New Stringency Indices for Nonpharmacological Social Distancing Policies Implemented in Korea During the COVID-19 Pandemic: Random Forest Approach.
    Apio C; Han K; Lee D; Lee B; Park T
    JMIR Public Health Surveill; 2024 Jan; 10():e47099. PubMed ID: 38190233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of good governance in the race for global vaccination during the COVID-19 pandemic.
    Tatar M; Faraji MR; Montazeri Shoorekchali J; Pagán JA; Wilson FA
    Sci Rep; 2021 Nov; 11(1):22440. PubMed ID: 34789826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker).
    Hale T; Angrist N; Goldszmidt R; Kira B; Petherick A; Phillips T; Webster S; Cameron-Blake E; Hallas L; Majumdar S; Tatlow H
    Nat Hum Behav; 2021 Apr; 5(4):529-538. PubMed ID: 33686204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
    COVID-19 Forecasting Team
    Lancet; 2022 Apr; 399(10334):1469-1488. PubMed ID: 35219376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.